Dergiler / Turkish Journal of Chemistry / 2021 / Cilt: 45 - Sayı: 4

Preconcentration of rifampicin prior to its efficient spectroscopic determination in the wastewater samples based on a nonionic surfactant

Sayfa
1201–1209
Yayın Tarihi
2022-11-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The standard addition methodology was adopted for the validation of this procedure and effectively applied for the determination of rifampicin in real wastewater samples.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Every year, tuberculosis affects the lungs of millions of people and rifampicin is the commonly used medicine for its treatment due to its antibiotic nature.
📊
Temel Bulgular & Veri:The frequent use of rifampicin may lead to its increased concentration in the water resources.
💡
Sonuç & Katkı:The standard addition methodology was adopted for the validation of this procedure and effectively applied for the determination of rifampicin in real wastewater samples.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Every year, tuberculosis affects the lungs of millions of people and rifampicin is the commonly used medicine for its treatment due to its antibiotic nature. The frequent use of rifampicin may lead to its increased concentration in the water resources. This research work is focused on the cloud point extraction (CPE) procedure for the preconcentration of rifampicin prior to its determination in water. The UV/vis spectrophotometric method was adapted for the measurement of rifampicin content after the phase separation. Triton-X 100 was used as the nonionic surfactant which contains hydrophilic polyethylene chain feasible for the extraction of analyte. Various analytical parameters that can affect the extraction efficacy were optimized to achieve linearity of the proposed method in the concentration range of 3.54–81.41 $mgL^{–1},$. The Limit of detection and quantification were 1.261 and 4.212 $mgL^{–1},$ respectively. The Preconcentration factor was 40 with relative standard deviation (%RSD) of 2.504%. The standard addition methodology was adopted for the validation of this procedure and effectively applied for the determination of rifampicin in real wastewater samples.

🔖

Bu Makaleye Atıf Yap

MUHAMMAD, H., ISMAIL, B., KHAN, A. U., SHAH, F., KHAN, R. A., KHAN, A. M. (2022). Preconcentration of rifampicin prior to its efficient spectroscopic determination in the wastewater samples based on a nonionic surfactant. Turkish Journal of Chemistry, Cilt: 45 - Sayı: 4, 1201–1209. https://ajindex.com/articles/601492

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Jongrungruangchok S, Songsak T. Validation of HPLC methods for determination of isoniazid, rifampicin, pyrazinamide, and ethambutolin a fixed-dose combination antituberculosis. Bulletin of Health, Science and Technology 2015; 13 (1): 17-28
  2. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8 (1): 1-9. doi: 10.1186/1471-2458-8-15 3. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011; 469 (7331): 483-490. doi: 10.1038/nature09657 4. Maggi N, Pasqualucci CR, Ballotta R, Sensi P. Rifampicin: a new orally active rifamycin. Chemotherapy 1966; 11 (5): 285-292. doi: 10.1159/000220462 5. Deepa P, Therese KL, Madhavan HN. Detection and characterization of mutations in rifampicin resistant Mycobacterium tuberculosis clinical isolates by DNA sequencing. Indian Journal of Tuberculosis 2005; 52 (3): 132-136
  3. Panchagnula R, Sood A, Sharda N, Kaur K, Kaul CL. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method. Journal of Pharmaceutical and Biomedical analysis 1999; 18 (6): 1013-1020. doi: 10.1016/ S0731-7085(98)00112-5 7. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979; 76 (6): 771-780. doi: 10.1378/chest.76.6.771 8. Diggelmann H, Weissmann C. Rifampicin inhibits focus formation in chick fibroblasts infected with Rous sarcoma virus. Nature 1969; 224 (5226): 1277-1279. doi: 10.1038/2241277a0 9. Hobby GL. Summation of experimental studies on the action of rifampin. Chest 1972; 61 (6): 550-554. doi: 10.1378/chest.61.6_ Supplement.550 10. Tatarczak M, Flieger J, Szumieo H. High perfomance liquid chromatographic determination of rifampicin in complex pharmaceutical preparation and in serum of Mycobacterium tuberculosis-infected patients. Acta Poloniae Pharmaceutica-Drug Research 2005; 62 (4): 251-256
  4. Cayley FE, Majumdar SK. Ocular toxicity due to rifampicin. British Medical Journal. 1976; 241 (6003): 199-200. doi: 10.1136/ bmj.1.6003.199-a 12. Polesky A, Farber HW, Gottlieb DJ, Park H, Levinson S et al. Rifampin preventive therapy for tuberculosis in Boston’s homeless. American Journal of Respiratory and Critical Care Medicine 1996; 154 (5): 1473-1477. doi: 10.1164/ajrccm.154.5.8912767 13. Pratt TH. Rifampin-induced organic brain syndrome. The Journal of the American Medical Association 1979; 241 (22): 2421-2422. doi: 10.1001/ja